In a study published in the Gold Bulletin journal by a group of researchers from the Center for Applied Physics and Advanced ...

Researchers, led by Dr Rafael T. M. de Rosales and Dr Graeme Stasiuk, have been awarded £10 million in funding from the ...

Research and development expenses were $12.2 million for the second quarter of 2025, compared to $14.7 million in the same period of 2024. Cash, cash equivalents, and short-term investments totaled ...

A bacteria-based cancer therapy has been engineered that eradicates tumors in immunocompromised mice—no immune cells required.

Researchers identified that triterpene glycosides from the starfish Solaster pacificus can kill drug-resistant prostate ...

Fermented pickles and olives can be a source of probiotics, but olives offer more when it comes to nutritional benefits.

Investors are reminded that Shareholders of record as of August 7, 2025, will receive a 15% stock dividend paymentLAWRENCEVILLE, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a ...

The OVATION-3 trial is designed to provide an early readout in HRD and BRCA1/2-mutated ovarian cancer patients, ideally leading to rapid filing and approval.